Adeshwar Meditex IPO is a Fixed Price listing on BSE SME exchange. The company is based in Mumbai and caters to Healthcare sector. Aryaman Financial Services is the merchant banker of Adeshwar Meditex IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 9th June 2021.
Adeshwar Meditex IPO posted revenues of ₹ 69.44 crores and PAT of ₹ 1.85 crores in FY21 on annualised basis.Financial results of Adeshwar Meditex IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Dec-20 | FY20 | FY19 | FY18 | |
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 65.60 | 54.80 | 43.86 | 32.81 | |
Net Worth | 20.20 | 18.81 | 15.79 | 13.54 | |
Total Debt | 21.65 | 21.91 | 19.91 | 11.46 | |
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
51.78
69.04 |
56.11 | 52.92 | 58.60 | |
EBITDA
EBITDA on annualised basis |
3.70
4.93 |
5.61 | 5.49 | 5.31 | |
PAT
PAT on annualised basis |
1.38
1.84 |
2.01 | 2.25 | 2.56 |
Adeshwar Meditex IPO PAT Margin is 2.67 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Adeshwar Meditex IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Dec-20 | FY20 | FY19 | FY18 |
---|---|---|---|---|
EBITDA Margin (%) | 7.15 | 10.00 | 10.37 | 9.06 |
PAT Margin (%) | 2.67 | 3.58 | 4.25 | 4.37 |
EPS (₹) | 1.32 | 2.00 | 2.26 | 2.96 |
ROE (%) | 6.83 | 10.69 | 14.25 | 18.91 |
ROCE (%) | [●] | [●] | [●] | [●] |
ROA (%) | 2.10 | 3.67 | 5.13 | 7.80 |
Debt to Equity | 1.07 | 1.16 | 1.26 | 0.85 |
The market Capitalisation of Adeshwar Meditex IPO is ₹ 36.20 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Adeshwar Meditex IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Adeshwar Meditex IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Adeshwar Meditex IPO is ₹ 36.20 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Adeshwar Meditex IPO has a Price-to-Earnings (PE) ratio of 19.53 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Adeshwar Meditex IPO reported revenue of ₹ 69.44 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Adeshwar Meditex IPO provide insights into sales growth, market demand, and business scalability.
Adeshwar Meditex recorded an EBITDA of ₹ 4.93 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Adeshwar Meditex Profit After Tax (PAT) is ₹ 1.84 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Adeshwar Meditex operates in Healthcare and Healthcare Provider. The Issue is listed on BSE SME in Jun, 2021. Adeshwar Meditex IPO size was 9.75 with Issue price of 25.00 .
Merchant Banker(s) of Adeshwar Meditex IPO: Aryaman Financial Services Limited
Adeshwar Meditex IPO subscription was 1.85 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Adeshwar Meditex IPO listed at a listing price of 25.25 against the offer price of 25.00.
The current market price of Adeshwar Meditex is 16.00.
Why Us?